Dietary acid load and its interaction with CETP TaqB1 polymorphisms on lipid profile among patients with Type 2 diabetes mellitus

Table 3 The interaction between CETP Taq1B polymorphism and PRAL on cardiovascular risk factors

Variables	DIL	Mean±SD			P₁	P₂
Variables	DIL	B1B1	B1B2	B2B2	Model (1)	Model (2)	P -trend
LDL (mg/dl)	T₁	108.1±10.52	123.85±4.8	128.53±8.59	0.009	0.009	0.02
	T₂	121.6±14.88	118.43±4.57	120.68±8.31
	T₃	146.75±16.63	113.11±4.33	104.7±10.52
HDL (mg/dl)		64.25±5.46	54.16±1.57	55.8±2.82	0.02	0.01	0.16
	T₁	64.25±5.46	54.16±1.57	55.8±2.82
	T₂	56 ±4.88	50.18±1.5	60.87±2.73
	T₃	51.9±3.45	51.89±1.42	50.8±3.45
LDL/HDL	T₁	2.26±3.39	2.31±1.54	2.38±2.77	<0.001	<0.001	0.001
	T₂	2.26±4.7	2.37±1.47	2.03±2.68
	T₃	4.81±5.36	2.26±1.39	2.09±3.39
TC (mg/dl)	T₁	196.1±23.97	206.83±10.94	217.85±20.26	0.02	0.04	0.19
	T₂	225±33.9	213.6±10.41	208.5±18.95
	T₃	299.25±37.9	204.81±9.86	216.9±23.97
TG (mg/dl)	T₁	155.6±36.46	194.8±17	188.33±29.77	0.001	0.001	0.04
	T₂	244.4±51.57	174.23±16.14	155.43±28.82
	T₃	381.75±57.65	175.77±15.14	180.3±36.46

Mean values of cardiovascular risk factors across CETP genotypes (B1B1, B1B2, B2B2) based on tertiles of PRAL intake
P₁ P-value for curd model, P₂ P-value for the adjusted model by age, gender, physical activity, smoking, alcohol consumption, and familial history of diabetes

ISSN: 1472-6823